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Abstract
We report the case of a 79-year-old man
with a tobacco smoke-related left dystrop-
hic bullous emphysema that showed a con-
siderable recovery of the cystic abnormali-
ties during chemotherapy for pleural malig-
nant mesothelioma. We suggest that the
disappearance of the dystrophic emphyse-
ma could be explained by the combined
effect of chemotherapy and pleural disease.
We briefly review the literature and we dis-
cuss the possible mechanism of this unfore-
seen manifestation.
Introduction
Malignant pleural mesothelioma is a
tumor that progressively involves the pleura
growing circumferentially along the chest
wall. As it arises from the pleura, different
manifestations can occur, including pleural
effusion, calcification and thickening,
extension beyond the diaphragm with either
contraction or enlargement of the hemitho-
rax, mediastinum expansion and lymph
nodes involvement.1-3 Herein, we describe
an odd manifestation of mesothelioma
occurring in a patient treated with first line
chemotherapy. We have conducted a brief
review of the literature and discussed the
possible reasons for this unforeseen phe-
nomenon.
Case Report
A 79-year-old man with asbestos expo-
sure and a tobacco smoke-related dystroph-
ic bullous emphysema – evident on chest
Computed Tomography (CT) since he was
70 – presented in February 2011 with pro-
gressive shortness of breath and left chest
pain. He underwent a chest CT scan that
revealed left bullous parenchymal distortion
associated to pleural thickening at the lower
lobe and right pleural effusion (Figure 1).
Considering the past environmental expo-
sure, a transthoracic needle biopsy of the
left pleura was performed and the diagnosis
of malignant pleural mesothelioma was
made. First line chemotherapy with cis-
platin and pemetrexed was delayed for
almost 3 months for the onset of infectious
complications (pneumonia and urosepsis),
then started with good toleration. Six weeks
from treatment start (2 cycles given) anoth-
er chest CT scan was performed showing a
considerable reduction of the dystrophic
cystic abnormalities with increased pleural
thickness of the left lobe (Figure 2). During
the time period between the two CT scan
the patient experienced a significant
improvement of the shortness of breath.
Pulmonary function tests were performed
showing an increased in lung volumes.
(Forced Vital Capacity changed from 1,87 L
to 2,13 L). The lung pseudo-restoration
remained evident in the 2 CT scans per-
formed until the patient died from septic
shock 12 months later.
Discussion and Conclusions
With this brief report we present an
unusual manifestation of pleural malignant
mesothelioma during chemotherapy. A 79-
year-old man with dystrophic parenchymal
bullae showed a consistent radiological
regression of the lung emphysema during
chemotherapy. Possible explanation for the
disappearance of the dystrophic emphyse-
ma could be found in the rupture of the
paraseptal bullae due to the treatment.4
There are very limited previously reported
data on this phenomenon and most reports
have been in patients with sarcoma or vis-
ceral pleural metastasis.5,6 Lee et al.
described the onset of spontaneous pneu-
mothorax resulting from intensive cytotoxic
chemotherapy.6 Different pathogenic mech-
anisms have been hypothesized: in particu-
lar the tumor necrosis due to the cytotoxic
effect of chemotherapy might directly
induce a breach in emphysematous bullae.7
In our case pneumothorax did not occur,
probably because of the symphysis due to
pleural thickening; this could have fixed the
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Figure 1. CT images of upper (A) and lower (B) lobes performed at the time of mesothe-
lioma diagnosis showing left lung volume reduction with diffuse peripheral cystic-bullous
abnormalities (white arrows), complete parenchymal distortion and right pleural effusion. 
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lung to the chest wall, avoiding its collapse
and resulting in parenchymal re-expansion.
While the effect of chemotherapy is one
hypothesis, an alternative explanation may
have been a circumferential growth of
mesothelioma that engulfed the lung pulling
the dystrophic emphysema towards the
pleura. Thus the lung tissue stretching could
have resulted in a pseudo-restoration. Even
if this explanation might be acceptable, the
chronological relationship with the begin-
ning of treatment seems to reinforce the role
of chemotherapy as the main cause of this
phenomenon.
In conclusion, besides the unusual
appearance, the depicted case seems inter-
esting since it occurred in a patient undergo-
ing chemotherapy. Through its description
we aimed to present an unforeseen manifes-
tation of pleural mesothelioma that has not
been reported yet.
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                             Case Report
Figure 2. CT images of upper (A) and lower (B) lobes performed 3 months from
chemotherapy start showing consistent reduction of the left pleural thickening with con-
sensual disappearance of the dystrophic cysts and considerable regression of the
parenchymal distortion at the left lower lobe (white arrows). Images show a mild increase
of the right pleural effusion.
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